Search Results

There are 37156 results for: content related to: Identification of spliced variants of the proto-oncogene hdm2 in colorectal cancer

  1. You have free access to this content
    Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein

    The EMBO Journal

    Volume 17, Issue 2, January 15, 1998, Pages: 554–564, Judith Roth, Matthias Dobbelstein, Deborah A. Freedman, Thomas Shenk and Arnold J. Levine

    Version of Record online : 15 JAN 1998, DOI: 10.1093/emboj/17.2.554

  2. You have free access to this content
    Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination

    The FEBS Journal

    Volume 279, Issue 3, February 2012, Pages: 370–383, Purvi Bhatt, Claire d’Avout, Naomi S. Kane, James A. Borowiec and Anjana Saxena

    Version of Record online : 19 DEC 2011, DOI: 10.1111/j.1742-4658.2011.08430.x

  3. You have free access to this content
    The ubiquitin–protein ligase activity of Hdm2 is inhibited by nucleic acids

    FEBS Letters

    Volume 554, Issue 1-2, November 06, 2003, Pages: 73–76, Laëtitia K Linares and Martin Scheffner

    Version of Record online : 8 OCT 2003, DOI: 10.1016/S0014-5793(03)01108-6

  4. You have free access to this content
    Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation

    The EMBO Journal

    Volume 21, Issue 14, July 15, 2002, Pages: 3715–3727, Zehavit Goldberg, Ronit Vogt Sionov, Michael Berger, Yaara Zwang, Ruth Perets, Richard A. Van Etten, Moshe Oren, Yoichi Taya and Ygal Haupt

    Version of Record online : 15 JUL 2002, DOI: 10.1093/emboj/cdf384

  5. You have free access to this content
    The mechanisms of regulation of Hdm2 protein level by serum growth factors

    FEBS Letters

    Volume 580, Issue 1, January 09, 2006, Pages: 300–304, Anna Phillips, Chris J. Jones and Jeremy P. Blaydes

    Version of Record online : 19 DEC 2005, DOI: 10.1016/j.febslet.2005.12.026

  6. You have free access to this content
    HDM2 negatively affects the Chk2-mediated phosphorylation of p53

    FEBS Letters

    Volume 579, Issue 12, May 09, 2005, Pages: 2604–2608, Marina Bjørling-Poulsen, David Meek and Olaf-Georg Issinger

    Version of Record online : 9 APR 2005, DOI: 10.1016/j.febslet.2005.03.081

  7. You have free access to this content
    p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma

    Cancer

    Volume 100, Issue 8, 15 April 2004, Pages: 1673–1682, Shoichi Mori, Genshi Ito, Noriyasu Usami, Hiromu Yoshioka, Yuichi Ueda, Yoshinori Kodama, Masahide Takahashi, Kwun M. Fong, Kaoru Shimokata and Yoshitaka Sekido

    Version of Record online : 18 MAR 2004, DOI: 10.1002/cncr.20164

  8. Thermodynamic and Computational Studies on the Binding of p53-Derived Peptides and Peptidomimetic Inhibitors to HDM2

    ChemBioChem

    Volume 10, Issue 8, May 25, 2009, Pages: 1360–1368, Anja Grässlin, Celine Amoreira, Kim K. Baldridge and John A. Robinson

    Version of Record online : 30 APR 2009, DOI: 10.1002/cbic.200900008

  9. Interference with p53 functions in human viral infections, a target for novel antiviral strategies?

    Reviews in Medical Virology

    Volume 21, Issue 5, September 2011, Pages: 285–300, Pedro A. Lazo and Claudio R. Santos

    Version of Record online : 1 JUL 2011, DOI: 10.1002/rmv.696

  10. You have free access to this content
    Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation

    The EMBO Journal

    Volume 23, Issue 7, April 7, 2004, Pages: 1547–1556, Jayne M Stommel and Geoffrey M Wahl

    Version of Record online : 18 MAR 2004, DOI: 10.1038/sj.emboj.7600145

  11. Structure–Activity Studies in a Family of β-Hairpin Protein Epitope Mimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

    ChemBioChem

    Volume 7, Issue 3, March 6, 2006, Pages: 515–526, Rudi Fasan, Ricardo L. A. Dias, Kerstin Moehle, Oliver Zerbe, Daniel Obrecht, Peer R. E. Mittl, Markus G. Grütter and John A. Robinson

    Version of Record online : 1 MAR 2006, DOI: 10.1002/cbic.200500452

  12. The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2

    Photochemistry and Photobiology

    Volume 92, Issue 2, March/April 2016, Pages: 318–324, Jianguo Feng, Li Li, Lingying Tong, Liling Tang and Shiyong Wu

    Version of Record online : 11 FEB 2016, DOI: 10.1111/php.12564

  13. A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors

    British Journal of Pharmacology

    Rike Wallbrecher, Patrick Chène, Stephan Ruetz, Therese Stachyra, Thomas Vorherr and Roland Brock

    Version of Record online : 6 JUL 2017, DOI: 10.1111/bph.13834

  14. You have full text access to this Open Access content
    A novel regulation of VEGF expression by HIF-1α and STAT3 in HDM2 transfected prostate cancer cells

    Journal of Cellular and Molecular Medicine

    Volume 16, Issue 8, August 2012, Pages: 1750–1757, Appu Rathinavelu, Madhusudhanan Narasimhan and Praneetha Muthumani

    Version of Record online : 29 JUL 2012, DOI: 10.1111/j.1582-4934.2011.01472.x

  15. Small molecule agents targeting the p53-MDM2 pathway for cancer therapy

    Medicinal Research Reviews

    Volume 32, Issue 6, November 2012, Pages: 1159–1196, Weisi Wang and Yongzhou Hu

    Version of Record online : 16 JAN 2011, DOI: 10.1002/med.20236

  16. You have free access to this content
    West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus

    Cellular Microbiology

    Volume 10, Issue 1, January 2008, Pages: 165–176, Mi-Ran Yang, Sung Ryul Lee, Wonkyung Oh, Eun-Woo Lee, Jung-Yong Yeh, Jin-Ju Nah, Yi-Seok Joo, Jaekyoon Shin, Han-Woong Lee, Suhkneung Pyo and Jaewhan Song

    Version of Record online : 26 JUL 2007, DOI: 10.1111/j.1462-5822.2007.01027.x

  17. You have free access to this content
    Study of the cytotoxic effect of a peptidic inhibitor of the p53–hdm2 interaction in tumor cells

    FEBS Letters

    Volume 529, Issue 2-3, October 09, 2002, Pages: 293–297, Patrick Chène, Jean Fuchs, Ilaria Carena, Pascal Furet and Carlos Garcı́a Echeverrı́a

    Version of Record online : 11 SEP 2002, DOI: 10.1016/S0014-5793(02)03362-8

  18. Effect of introducing aib in a designed helical inhibitor of hdm2-p53 interaction: A molecular dynamics study

    Peptide Science

    Volume 106, Issue 1, January 2016, Pages: 51–61, Sarbani Chattopadhyay, Haresh Ajani and Gautam Basu

    Version of Record online : 27 JAN 2016, DOI: 10.1002/bip.22761

  19. An antibody-free strategy for screening putative HDM2 inhibitors using crude bacterial lysates expressing GST-HDM2 recombinant protein

    Drug Testing and Analysis

    Volume 5, Issue 7, July 2013, Pages: 596–601, Barbara Costa, Agostina Francesca Grillone, Alessandra Salvetti, Silvia Rocchiccioli, Paola Iacopetti, Simona Daniele, Eleonora Da Pozzo, Pietro Campiglia, Ettore Novellino, Claudia Martini and Leonardo Rossi

    Version of Record online : 4 JUN 2013, DOI: 10.1002/dta.1492

  20. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy

    Histopathology

    Volume 46, Issue 2, February 2005, Pages: 184–194, J-C Martínez, J-C Palomino, A Cabello, J M Sepúlveda, A G De La Cámara and J-R Ricoy

    Version of Record online : 5 FEB 2005, DOI: 10.1111/j.1365-2559.2005.02074.x